1. Israel Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Nutritional Growth Solutions Ltd.

Nutritional Growth Solutions Ltd.

AASX:NGS
0.02
AUD
+0.00
(-15.00%)
-0.01EPS
7.35MMarket Cap
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
0.13
0.23
0.21
0.1
0.04
0.01
Basic EPS, GAAP
-0.31
-0.36
-0.3
-0.1
-0.04
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
0.23
0.24
0.14
- -
-0.01
- -
Tangible Book Value per Share
0.22
0.23
0.14
- -
-0.01
- -
Basic Weighted Avg Shares
11
10
14
29
69
171
Sales/Revenue/Turnover
1
2
3
3
2
2
Operating Margin (%)
-120.75
-122.07
-147.4
-102.92
-114.15
-97.85
Depreciation Expense
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-3
-3
-4
-3
-3
-2
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-233.21
-157.24
-144.18
-96.75
-116.85
-104.06
Working Capital
4
3
3
- -
-1
- -
LT Debt
- -
- -
- -
- -
- -
- -
Total Equity
3
3
2
- -
-1
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-113.13
-173.72
- -
- -
- -

Capital Structure

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
110.19%
-141.11%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
-9.48%
-41.6%
Sales/Revenue/Turnover
- -
7.38%
-34.42%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
3
2024
- -
- -
2
2025
- -
- -
2

Semi-annual Earnings Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.1
2024
- -
- -
-0.04
2025
- -
- -
-0.01

Semi-annual Dividends Per Share

USD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Selasi Berdie
Full Time Employees
6
Sector
Health technology
Industry
Pharmaceuticals: other
Address
2 Nexus Court Tel Aviv VIC Israel 3170
IPO Date
Oct 26, 2020
Website
ngsolutions.co
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Nutritional Growth Solutions Ltd. (ASX:NGS) develops, produces and sells clinically proven pediatric nutritional supplements designed to support child growth and development, primarily through protein shakes and powders rich in whey protein, vitamins, minerals and macro and micro nutrients; its core brands include Healthy Height, marketed in the United States, Italy and Asia Pacific; Pro Up, distributed to pediatricians and dietitians in Israel; and Horlicks, licensed to GlaxoSmithKline for production, distribution and marketing in territories including India. The Tel Aviv, Israel-headquartered company, founded in 2013 and formerly known as N.G. Solutions Ltd. until its name change in June 2020, operates primarily in the United States with additional international presence targeting picky eaters and undernourished children through direct-to-consumer, retail and professional channels. In recent developments, the company secured commitments for a A$2 million capital raise via share placement at A$0.02 per share to fund US expansion, increased production capacity and retail growth beyond Walmart; it also reported Q3 FY25 revenue of US$486k, reflecting a 13% sequential increase, and surpassed US$500k in Healthy Height sales in South Africa as part of ongoing geographic diversification.